Presentation is loading. Please wait.

Presentation is loading. Please wait.

Cilostazol reduces restenosis after endovascular therapy in patients with femoropopliteal lesions  Osamu Iida, MD, Shinsuke Nanto, MD, Masaaki Uematsu,

Published byMax Nilsson Modified over 5 years ago

Similar presentations

Presentation on theme: "Cilostazol reduces restenosis after endovascular therapy in patients with femoropopliteal lesions  Osamu Iida, MD, Shinsuke Nanto, MD, Masaaki Uematsu,"— Presentation transcript:

1 Cilostazol reduces restenosis after endovascular therapy in patients with femoropopliteal lesions 
Osamu Iida, MD, Shinsuke Nanto, MD, Masaaki Uematsu, MD, Takakazu Morozumi, MD, Masafumi Kitakaze, MD, Seiki Nagata, MD  Journal of Vascular Surgery  Volume 48, Issue 1, Pages (July 2008) DOI: /j.jvs Copyright © 2008 The Society for Vascular Surgery Terms and Conditions

2 Fig 1 Patency after endovascular therapy (primary end point) for symptomatic de novo femoropopliteal lesions compared between patients receiving cilostazol (solid circles) and ticlopidine (clear circles). Patency was evaluated by duplex ultrasonography (peak systolic velocity ratio >2.4). (A) By intention-to-treat analysis, patency rates at 12, 24, and 36 months were 87%, 82%, and 73% in the cilostazol group and 65%, 60%, and 51% in ticlopidine group (P = .013). (B) By as-treated analysis, patency rates at 12, 24, and 36 months were 87%, 82%, and 73% in the cilostazol group and 64%, 57%, and 48% in ticlopidine group (P = .0088). Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2008 The Society for Vascular Surgery Terms and Conditions

3 Fig 2 Patency for the different types of stent used: nitinol stents (NI, filled symbol) vs cobalt metallic stents (Co, open symbol) compared between the cilostazol (circles) group and the ticlopidine (squares) group. Patency of nitinol stents used in the cilostazol group tended to be the highest among the groups (P = .09). Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2008 The Society for Vascular Surgery Terms and Conditions

4 Fig 3 Freedom from target lesion revascularization (TLR) compared between the cilostazol (circles) group and the ticlopidine (squares) group (secondary end point). Freedom from TLR at 12, 24, and 36 months was significantly higher in the cilostazol group than in the ticlopidine group (88%, 82%, and 82% vs 73%, 70%, and 58%; P = .036). Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2008 The Society for Vascular Surgery Terms and Conditions

5 Fig 4 Freedom from all adverse events (secondary end point), including death, amputation and restenosis was significantly higher at 12, 24, and 36 months in patients treated with cilostazol (circles) than in those treated with ticlopidine (squares): 77%, 72%, and 60% vs 60%, 50%, and 41% (P = .031). Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2008 The Society for Vascular Surgery Terms and Conditions

Download ppt "Cilostazol reduces restenosis after endovascular therapy in patients with femoropopliteal lesions  Osamu Iida, MD, Shinsuke Nanto, MD, Masaaki Uematsu,"

Similar presentations

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.
Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.
Without prejudice Journal of Vascular Surgery

Without prejudice Journal of Vascular Surgery
Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.
Carotid artery stenting may be performed safely in patients with radiation therapy- associated carotid stenosis without increased restenosis or target.

Carotid artery stenting may be performed safely in patients with radiation therapy- associated carotid stenosis without increased restenosis or target.
Restenosis in gold-coated renal artery stents

Restenosis in gold-coated renal artery stents
Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents  Yiu Che Chan, MBBS, BSc, MD, FRCS, Stephen W.

Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents  Yiu Che Chan, MBBS, BSc, MD, FRCS, Stephen W.
EXCITE ISR Trial design: Participants with femoropopliteal in-stent restenosis were randomized to excimer laser atherectomy + adjunctive angioplasty (n.

EXCITE ISR Trial design: Participants with femoropopliteal in-stent restenosis were randomized to excimer laser atherectomy + adjunctive angioplasty (n.
Incidence, predictors, and prognosis of in-stent occlusion after endovascular treatment with nitinol stents for femoropopliteal lesions  Tomoharu Dohi,

Incidence, predictors, and prognosis of in-stent occlusion after endovascular treatment with nitinol stents for femoropopliteal lesions  Tomoharu Dohi,
Stenting of femoropopliteal lesions using interwoven nitinol stents

Stenting of femoropopliteal lesions using interwoven nitinol stents
First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease  Johannes Lammer, MD, Marc.

First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease  Johannes Lammer, MD, Marc.
Misaki M. Kiguchi, MD, MBA, Luke K. Marone, MD, Rabih A

Misaki M. Kiguchi, MD, MBA, Luke K. Marone, MD, Rabih A
A percutaneous arterial closure protocol can decrease complications after endovascular interventions in vascular surgery patients  Philip P. Goodney,

A percutaneous arterial closure protocol can decrease complications after endovascular interventions in vascular surgery patients  Philip P. Goodney,
Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease 

Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease 
Ali F. AbuRahma, MD, J. David Hayes, MD, Sarah K

Ali F. AbuRahma, MD, J. David Hayes, MD, Sarah K
Open bypass and endovascular procedures among diabetic foot ulcer cases in the United States from 2001 to 2010  Grant H. Skrepnek, PhD, David G. Armstrong,

Open bypass and endovascular procedures among diabetic foot ulcer cases in the United States from 2001 to 2010  Grant H. Skrepnek, PhD, David G. Armstrong,
Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions  Takao Ohki, MD, PhD, Kimihiko.

Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions  Takao Ohki, MD, PhD, Kimihiko.
Results of the United States multicenter prospective study evaluating the Zenith fenestrated endovascular graft for treatment of juxtarenal abdominal.

Results of the United States multicenter prospective study evaluating the Zenith fenestrated endovascular graft for treatment of juxtarenal abdominal.
Duplex ultrasound criteria for femorofemoral bypass revision

Duplex ultrasound criteria for femorofemoral bypass revision
Early duplex scanning after infrainguinal endovascular therapy

Early duplex scanning after infrainguinal endovascular therapy

Similar presentations

Ads by Google